Episode 49

How AI is Shaping Biotech? Expert Insights from James Bilotta

In this episode of Biotech Bytes, James Bilotta, SVP and CIO at Dyne Therapeutics, discusses the evolving role of technology leaders in biotech and how AI is reshaping the industry. James shares his journey from hospital informatics to leading digital transformation in high-growth biotech companies.Please visit our website to get more information: https://swangroup.net/

In this video, we explore the growing importance of AI in making business decisions, improving processes, and ensuring compliance in biotech. James also explains how AI is helping organizations scale, innovate, and bring therapies to market more efficiently, while keeping patients at the center of everything.

This conversation covers:

✅ The shifting role of the CIO in biotech

✅ How biotech companies are identifying AI use cases

✅ Practical advice for young professionals in IT

✅ The importance of AI governance and leadership alignment

Don’t miss insights on how AI is not only transforming operations but also enabling companies to be more competitive while managing risk.

Links from this episode:

✅ Get to know more about Steven Swan: https://www.linkedin.com/in/swangroup

✅ Get to know more about James Bilotta: https://www.linkedin.com/in/james-bilotta-7a06607

✅ Learn more about Dyne Therapeutics: https://www.dyne-tx.com/

TimeStamps

00:00 – Introduction